These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 11830543

  • 1. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
    Jackson MW, Roberts JS, Heckford SE, Ricciardelli C, Stahl J, Choong C, Horsfall DJ, Tilley WD.
    Cancer Res; 2002 Feb 01; 62(3):854-9. PubMed ID: 11830543
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.
    Ravindranath N, Wion D, Brachet P, Djakiew D.
    J Androl; 2001 Feb 01; 22(3):432-43. PubMed ID: 11330643
    [Abstract] [Full Text] [Related]

  • 3. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor Flk-1 in benign, premalignant, and malignant prostate tissue.
    Köllermann J, Helpap B.
    Am J Clin Pathol; 2001 Jul 01; 116(1):115-21. PubMed ID: 11447740
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.
    Tian X, Song S, Wu J, Meng L, Dong Z, Shou C.
    Biochem Biophys Res Commun; 2001 Aug 24; 286(3):505-12. PubMed ID: 11511087
    [Abstract] [Full Text] [Related]

  • 5. Angiogenesis and prostate cancer: identification of a molecular progression switch.
    Huss WJ, Hanrahan CF, Barrios RJ, Simons JW, Greenberg NM.
    Cancer Res; 2001 Mar 15; 61(6):2736-43. PubMed ID: 11289156
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma.
    Strizzi L, Catalano A, Vianale G, Orecchia S, Casalini A, Tassi G, Puntoni R, Mutti L, Procopio A.
    J Pathol; 2001 Apr 15; 193(4):468-75. PubMed ID: 11276005
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
    Gilbert RE, Vranes D, Berka JL, Kelly DJ, Cox A, Wu LL, Stacker SA, Cooper ME.
    Lab Invest; 1998 Aug 15; 78(8):1017-27. PubMed ID: 9714188
    [Abstract] [Full Text] [Related]

  • 8. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
    Valter MM, Hügel A, Huang HJ, Cavenee WK, Wiestler OD, Pietsch T, Wernert N.
    Cancer Res; 1999 Nov 01; 59(21):5608-14. PubMed ID: 10554042
    [Abstract] [Full Text] [Related]

  • 9. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor.
    Balbay MD, Pettaway CA, Kuniyasu H, Inoue K, Ramirez E, Li E, Fidler IJ, Dinney CP.
    Clin Cancer Res; 1999 Apr 01; 5(4):783-9. PubMed ID: 10213213
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V, Mukunyadzi P, Dennis RA, Siegel ER, Johnson DE, Kohli M.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [Abstract] [Full Text] [Related]

  • 15. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D, Jimenez X, Zhang H, Wu Y, Bohlen P, Witte L, Zhu Z.
    Cancer Res; 2001 Oct 01; 61(19):7002-8. PubMed ID: 11585724
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.
    Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, Carbone M, Watanabe Y, Pass HI.
    Br J Cancer; 1999 Sep 01; 81(1):54-61. PubMed ID: 10487612
    [Abstract] [Full Text] [Related]

  • 18. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.
    Anticancer Res; 2002 Sep 01; 22(6C):3977-84. PubMed ID: 12553021
    [Abstract] [Full Text] [Related]

  • 19. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA, Paavonen K.
    Microsc Res Tech; 2001 Oct 15; 55(2):108-21. PubMed ID: 11596156
    [Abstract] [Full Text] [Related]

  • 20. Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells.
    Chen HJ, Treweeke AT, Ke YQ, West DC, Toh CH.
    Br J Cancer; 2000 May 15; 82(10):1694-701. PubMed ID: 10817506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.